When health apps meet VR
How AR, VR and gamification technology is being integrated with AI apps to enhance health outcomes
18th July 2018
Web Exclusives
Brexit: the good, the bad and the ugly
Colin Newbould, director of regulatory affairs and QP services at The Wasdell Group, on what the worst and best case Brexit scenarios could be mean for contract services and the wider pharma industry
17th July 2018
Is data holding you back?
How data trends in the financial services sector could transform pharma
16th July 2018
Medtech: challenges of a healthcare revolution
A new report looks into how medtech must address key problems
12th July 2018
Medical data and the rise of blockchain
Blockchain technology could be game-changing for electronic medical records, but new GDPR rules need to be taken into account
6th July 2018
Value-based healthcare: matching who benefits with who pays
Seeking success in value-based healthcare
3rd July 2018
Human nature: the next frontier for pharma?
A new survey reveals pharma’s thoughts on patient support prgrammes
29th June 2018
Opinions differ widely for new pricing models
Issues from Brexit to the impact of curative therapies mean that innovation in drug pricing must accelerate
28th June 2018
Creating a wave of change in the Mental Health Act
Workers from Adelphi Research UK, Rethink Mental Illness and Janssen recently picked up the award for Best Conference Paper at the British Healthcare Business Intelligence Association (BHBIA) Conference for their pro-bono work to change the Mental Health Act. Here’s their story
22nd June 2018
Making labels comply with MDR
The new European Medical Devices Regulation (MDR) is forcing companies to review their labeling infrastructure as they battle for organisational preparedness
19th June 2018
How to double the productivity of your discovery scientists
A modular approach to omics data architecture could give discovery scientists back fifty per cent of their time
18th June 2018
Learning from both success and failure in severe asthma
The NIHR's Professor Chris Brightling explains how negative results from an asthma study can teach us just as much as positive results
15th June 2018
Late to regenerate
Are current regulatory frameworks hindering therapy development for regenerative medicine?
12th June 2018
At the crossroads of engineering and medicine
The current state of the tissue engineering market
11th June 2018
Guilty? Are We?
Graham Kershaw, Managing Director of packaging designers and manufacturers, Macpac, addresses consumer and some media concerns in regard to packaging waste – Guilty? Are We?
4th June 2018
